Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer-a narrative review. | Transl Androl Urol | 2021 | 34430421 | PubTator, text mining | PubMed |
| Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cells. | Sci Rep | 2021 | 34408239 | PubTator, text mining | PubMed |
| Two Amphioxus ApeC-Containing Proteins Bind to Microbes and Inhibit the TRAF6 Pathway. | Front Immunol | 2021 | 34394119 | PubTator, text mining | PubMed |
| Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications. | Front Oncol | 2021 | 34381724 | PubTator, text mining | PubMed |
| Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T. | J Immunother Cancer | 2021 | 34376554 | PubTator, text mining | PubMed |
| Glycosylation: Rising Potential for Prostate Cancer Evaluation. | Cancers (Basel) | 2021 | 34359624 | PubTator, text mining | PubMed |
| Optical-Based Biosensors and Their Portable Healthcare Devices for Detecting and Monitoring Biomarkers in Body Fluids. | Diagnostics (Basel) | 2021 | 34359368 | PubTator, text mining | PubMed |
| MELD-accelerated molecular dynamics help determine amyloid fibril structures. | Commun Biol | 2021 | 34354239 | PubTator, text mining | PubMed |
| Alterations in protein expression and site-specific N-glycosylation of prostate cancer tissues. | Sci Rep | 2021 | 34354152 | PubTator, text mining | PubMed |
| Longitudinal stability of urinary extracellular vesicle protein patterns within and between individuals. | Sci Rep | 2021 | 34341426 | PubTator, text mining | PubMed |
| Emerging role of circulating tumor cells in immunotherapy. | Theranostics | 2021 | 34335980 | PubTator, text mining | PubMed |
| Targeting neoantigens for cancer immunotherapy. | Biomark Res | 2021 | 34321091 | PubTator, text mining | PubMed |
| Developmental validation of a multiplex proteomic assay for the identification of forensically relevant biological fluids. | Forensic Sci Int | 2021 | 34311288 | PubTator, text mining | PubMed |
| A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation. | J Exp Clin Cancer Res | 2021 | 34301276 | PubTator, text mining | PubMed |
| Compatibility of Distinct Label-Free Proteomic Workflows in Absolute Quantification of Proteins Linked to the Oocyte Quality in Human Follicular Fluid. | Int J Mol Sci | 2021 | 34299044 | PubTator, text mining | PubMed |
| Glycoproteins Presenting Galactose and N-Acetylgalactosamine in Human Seminal Plasma as Potential Players Involved in Immune Modulation in the Fertilization Process. | Int J Mol Sci | 2021 | 34298952 | PubTator, text mining | PubMed |
| Case report of peritoneal carcinomatosis of plasma cell origin in a patient with newly diagnosed HIV: A terminal event. | AIDS Res Ther | 2021 | 34281559 | PubTator, text mining | PubMed |
| HFS-SLPEE: A Novel Hierarchical Feature Selection and Second Learning Probability Error Ensemble Model for Precision Cancer Diagnosis. | Front Cell Dev Biol | 2021 | 34277640 | PubTator, text mining | PubMed |
| Dynamic changes of plasma extracellular vesicle long RNAs during perioperative period of colorectal cancer. | Bioengineered | 2021 | 34266354 | PubTator, text mining | PubMed |
| Targeting the spectrum of immune checkpoints in prostate cancer. | Expert Rev Clin Pharmacol | 2021 | 34263692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=25